154 related articles for article (PubMed ID: 4087137)
1. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
[TBL] [Abstract][Full Text] [Related]
2. The effects of short-term administration of ibuprofen on trimethadione metabolism and antipyrine metabolite formation in the rat.
Tanaka E; Kobayashi S; Oguchi K; Kuroiwa Y; Yasuhara H
Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):317-20. PubMed ID: 4023417
[TBL] [Abstract][Full Text] [Related]
3. Effects of cimetidine and diethylaminoethyl 2,2-diphenylvalerate HCL (SKF 525-A) on trimethadione metabolism in the rat.
Tanaka E; Misawa S; Kuroiwa Y
J Pharmacobiodyn; 1985 Sep; 8(9):767-72. PubMed ID: 4087136
[TBL] [Abstract][Full Text] [Related]
4. Effects of cimetidine and ranitidine on trimethadione metabolism in the rat.
Tanaka E; Misawa S
Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):461-4. PubMed ID: 3992022
[TBL] [Abstract][Full Text] [Related]
5. Effects of allyl alcohol and bromobenzene on trimethadione metabolism in the rat.
Tanaka E; Nakamura T; Misawa S; Yoshida T; Kuroiwa Y
Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):137-51. PubMed ID: 6473897
[TBL] [Abstract][Full Text] [Related]
6. Relationship between trimethadione metabolism and hepatic drug-oxidizing enzyme activities in different animal species.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
J Pharmacobiodyn; 1983 Jul; 6(7):481-6. PubMed ID: 6644533
[TBL] [Abstract][Full Text] [Related]
7. Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man.
Tanaka E; Nakamura K
Eur J Clin Pharmacol; 1989; 36(6):629-32. PubMed ID: 2776822
[TBL] [Abstract][Full Text] [Related]
8. Studies on the trimethadione metabolism as a tool for the assessment of drug-metabolizing capacity using plasma and urine of rats pretreated with phenobarbital and 3-methylcholanthrene.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
J Pharmacobiodyn; 1982 Mar; 5(3):162-71. PubMed ID: 7097483
[TBL] [Abstract][Full Text] [Related]
9. A method for estimation of hepatic drug-metabolizing capacity: determination of concentration of trimethadione and its metabolite in human serum.
Kobayashi S; Tanaka E; Oguchi K; Yoshida T; Kuroiwa Y; Yasuhara H
J Pharmacobiodyn; 1984 May; 7(5):329-35. PubMed ID: 6470930
[TBL] [Abstract][Full Text] [Related]
10. Trimethadione as a model drug for the evaluation of hepatic drug-metabolizing capacity in normal and alpha-naphthylisothiocyanate-intoxicated rats.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
Pharmacology; 1982; 25(4):202-9. PubMed ID: 7146085
[TBL] [Abstract][Full Text] [Related]
11. The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
Sakai H; Kobayashi S; Hamada K; Iida S; Akita H; Tanaka E; Uchida E; Yasuhara H
Br J Clin Pharmacol; 1991 Mar; 31(3):353-5. PubMed ID: 2054276
[TBL] [Abstract][Full Text] [Related]
12. Induction of cytochrome P-450 and related drug-oxidizing activities in muscone (3-methylcyclopentadecanone)-treated rats.
Tanaka E; Kurata N; Kohno M; Yoshida T; Kuroiwa Y
Biochem Pharmacol; 1987 Dec; 36(24):4263-7. PubMed ID: 3689452
[TBL] [Abstract][Full Text] [Related]
13. Determination of plasma trimethadione and its metabolite carbon tetrachloride-intoxicated rat liver: a useful tool for estimation of hepatic drug metabolizing capacity.
Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
J Pharmacobiodyn; 1981 Dec; 4(12):961-7. PubMed ID: 7341752
[TBL] [Abstract][Full Text] [Related]
14. Dual effects of a novel thienodiazepine platelet-activating factor antagonist, on drug-oxidizing enzymes in beagle dog.
Tanaka E; Daling Z; Abe K; Nakamura T; Horie T
Xenobiotica; 1994 Apr; 24(4):293-300. PubMed ID: 8059533
[TBL] [Abstract][Full Text] [Related]
15. Sex-related differences in hepatic drug-oxidizing capacity of streptozotocin-induced diabetic rats.
Tanaka E; Ishikawa A; Misawa S; Kuroiwa Y
J Pharmacobiodyn; 1988 Jun; 11(6):416-23. PubMed ID: 3050023
[TBL] [Abstract][Full Text] [Related]
16. Effect of E-5110, a novel non-steroidal anti-inflammatory drug, on trimethadione metabolism as an indicator of hepatic drug-oxidizing capacity in beagle dog.
Daling Z; Tanaka E; Nakamura T; Horie T
Xenobiotica; 1994 Mar; 24(3):215-20. PubMed ID: 8009884
[TBL] [Abstract][Full Text] [Related]
17. Trimethadione metabolism, a useful indicator for assessing hepatic drug-oxidizing capacity.
Nakamura M; Tanaka E; Misawa S; Shimada T; Imaoka S; Funae Y
Biochem Pharmacol; 1994 Jan; 47(2):247-51. PubMed ID: 8304968
[TBL] [Abstract][Full Text] [Related]
18. The effects of selective cytochrome P-450 inducing agents on trimethadione metabolism as an indicator of hepatic drug-oxidizing capacity in rats.
Tanaka E; Etoh H; Misawa S
Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):375-8. PubMed ID: 2385760
[No Abstract] [Full Text] [Related]
19. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
Danhof M; Krom DP; Breimer DD
Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
[TBL] [Abstract][Full Text] [Related]
20. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]